{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:19:48Z","timestamp":1792790388525,"version":"4.5.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.06.044","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T20:22:06Z","timestamp":1530735726000},"page":"4979-4992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["A report on the status of vaccination in Europe"],"prefix":"10.1016","volume":"36","author":[{"given":"Shazia","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Biundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soizic","family":"Courcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherina","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Poscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Szucs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Begg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2018.06.044_b0005","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1080\/21645515.2015.1019980","article-title":"The future of immunization policies in Italy and in the European Union: the declaration of Erice","volume":"11","author":"Odone","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.06.044_b0010","doi-asserted-by":"crossref","first-page":"A18","DOI":"10.1016\/j.vaccine.2010.02.027","article-title":"National immunization technical advisory groups (NITAGs): guidance for their establishment and strengthening","volume":"28","author":"Duclos","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.044_b0015","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.9.21049","article-title":"Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, April 2014","volume":"20","author":"Takla","year":"2015","journal-title":"Euro Surveill"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.044_b0020","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/1469-0691.12315","article-title":"National Advisory Groups and their role in immunization policy-making processes in European countries","volume":"19","author":"Nohynek","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.06.044_b0025","unstructured":"World Health Organization. European Vaccine Action Plan (EVAP); 2015-2020. <http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0007\/255679\/WHO_EVAP_UK_v30_WEBx.pdf?ua=1>. Accessed 28-05-2018."},{"key":"10.1016\/j.vaccine.2018.06.044_b0030","unstructured":"European Centre for Disease Prevention and Control. Current practices in immunisation policymaking in European countries; 2017. <https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/Current-practices-on-immunisation-policymaking-processes-Mar-2015.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0035","unstructured":"Ludwig Boltzmann Institute \u2013 Health Technology Assessment; 2017 <http:\/\/hta.lbg.ac.at\/page\/alle-projekte-im-ueberblick\/en>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0040","unstructured":"KCE \u2013 Federaal Kenniscentrum voor de Gezondheidszorg; 2017. <https:\/\/kce.fgov.be\/nl>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0045","unstructured":"BULGARIA \u2013 Recent and planned developments in pharmaceutical policies 2015; 2017. <http:\/\/whocc.goeg.at\/Literaturliste\/Dokumente\/CountryInformationPosters\/BG_Poster_2015.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0050","unstructured":"Agencija za kvalitetu i akreditaciju u zdravstvu i socijalnoj skrbi; 2017. <http:\/\/www.aaz.hr\/hr\/kvaliteta>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0055","unstructured":"National Institute for Health and Welfare. Terveyden ja hyvinvoinnin laitos; 2017. <https:\/\/thl.fi\/fi>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0060","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Le point sur les vaccinations; 2017. <http:\/\/www.hcsp.fr\/Explore.cgi\/PointSur?clef=1>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0065","unstructured":"Le Comit\u00e9 d'\u00e9valuation des technologies de sant\u00e9 (CEDIT); 2017. <http:\/\/cedit.aphp.fr\/>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0070","unstructured":"World Health Organization (WHO). Access to medicines in Europe \u2013 technical review of policy initiatives and opportunities for collaboration and research; 2017. <http:\/\/apps.who.int\/medicinedocs\/documents\/s21793en\/s21793en.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0075","unstructured":"Agenzia Nazionale per i servizi sanitari Regionali; 2017. <http:\/\/www.agenas.it\/aree-tematiche\/hta-health-technology-assessment\/hs-horizon-scanning\/report-hs>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0080","unstructured":"Gezondheidsraad \u2013 Health Council of the Netherlands; 2017. <https:\/\/www.gezondheidsraad.nl\/sites\/default\/files\/0508n.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0085","unstructured":"Poland \u2013 Recent and planned developments in pharmaceutical policies 2015; 2017. <http:\/\/whocc.goeg.at\/Literaturliste\/Dokumente\/CountryInformationPosters\/PL_Poster_2015.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0090","unstructured":"World Health Organization (WHO). Global summary 2017 Romania; 2017. <http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=ROU>. [Accessed 9\/25\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0095","unstructured":"Spanish Network of Agencies for Assessing National Health System Technologies and Performance; 2017. <http:\/\/www.redets.msssi.gob.es\/en\/home.htm>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0100","unstructured":"Sweden \u2013 Recent and planned developments in pharmaceutical policies 2015; 2017. <http:\/\/whocc.goeg.at\/Literaturliste\/Dokumente\/CountryInformationPosters\/SE_Poster_2015.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0105","unstructured":"Switzerland \u2013 Recent and planned developments in pharmaceutical policies 2015; 2017. <http:\/\/whocc.goeg.at\/Literaturliste\/Dokumente\/CountryInformationPosters\/CH_Poster_2015.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0110","unstructured":"National Institute of Health Research \u2013 Innovation Observatory (IO \u2013 NIHR); 2017. <http:\/\/www.io.nihr.ac.uk\/>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0115","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI). Horizon Scanning Report Form; 2017. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/287887\/JCVI_Horizon_Scanning_Guidance_2014.pdf>. [Accessed 8\/7\/2017]."},{"issue":"4","key":"10.1016\/j.vaccine.2018.06.044_b0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/INF.0b013e3181c18434","article-title":"Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children","volume":"29","author":"Paulke-Korinek","year":"2010","journal-title":"Pediatric Infect Disease J"},{"key":"10.1016\/j.vaccine.2018.06.044_b0125","unstructured":"Conseil Superieur d'Hygiene. Vaccination du nourrisson contre les gastro-ent\u00e9rites \u00e0 rotavirus; 2017. <http:\/\/www.nitag-resource.org\/uploads\/media\/default\/0001\/02\/2131a029da791c99883cdf7577fc566d24f5a82b.pdf>. [Accessed 8\/7\/2017]."},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2018.06.044_b0130","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1016\/j.vaccine.2011.04.098","article-title":"Impact of rotavirus vaccination on laboratory confirmed cases in Belgium","volume":"29","author":"Hanquet","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.044_b0135","unstructured":"Government Bulgaria. National Rotavirus Program; 2017. <http:\/\/www.government.bg\/cgi-bin\/e-cms\/vis\/vis.pl?s=001&p=0228&n=8951&g>. [Accessed 9\/25\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0140","unstructured":"European Centre for Disease Prevention and Control. Vaccine Schedule; 2017. <http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx>. [Accessed 8\/7\/2017]."},{"issue":"7","key":"10.1016\/j.vaccine.2018.06.044_b0145","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00103-013-1777-3","article-title":"Background paper to the recommendation for routine rotavirus vaccination of infants in Germany","volume":"56","author":"Koch","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.vaccine.2018.06.044_b0150","unstructured":"Robert Koch Institute. Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: August 2013; 2017. <http:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2013\/Ausgaben\/34_13.pdf?__blob=publicationFile>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0155","unstructured":"Vaccination for rotavirus gastroenteritis; 2017. <http:\/\/www2.keelpno.gr\/blog\/?p=3398&lang=en>. [Accessed 8\/7\/2017]."},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.044_b0160","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(14)70035-0","article-title":"Rotavirus vaccination in Europe: drivers and barriers","volume":"14","author":"Parez","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.044_b0165","unstructured":"Ministero della Salute. Piano Nazionale Prevenzione Vaccinale 2017-2019; 2017. <http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf>. [Accessed 8\/7\/2017]."},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.044_b0170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5114\/aoms.2016.59935","article-title":"The effectiveness of rotavirus vaccine in preventing acute gastroenteritis during rotavirus seasons among Polish children","volume":"12","author":"Mrozek-Budzyn","year":"2016","journal-title":"Arch Med Sc"},{"key":"10.1016\/j.vaccine.2018.06.044_b0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.socscimed.2016.02.006","article-title":"\u201cSaving lives\u201d: adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria","volume":"153","author":"Paul","year":"2016","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2018.06.044_b0180","unstructured":"KCE \u2013 Centre F\u00e9d\u00e9ral d'Expertise des Soins de Sant\u00e9. HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment; 2017. <https:\/\/kce.fgov.be\/sites\/default\/files\/page_documents\/d20071027343.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0185","unstructured":"Conseil Sup\u00e9rieur de la Sant\u00e9. Vaccination contre les infections caus\u00e9es par le papillomavirus humain \u2013 D\u00e9cembre 2007; 2017. <https:\/\/www.health.belgium.be\/sites\/default\/files\/uploads\/fields\/fpshealth_theme_file\/13328488\/Brochure%20HPV.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0190","unstructured":"Ministry of Health. National HPV Program. 2017. <http:\/\/www.mh.government.bg\/bg\/novini\/ministerski-savet\/kabinett-prie-natsionalna-programa-za-prvichna-pro\/>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0195","unstructured":"Croatia Vaccination implementation program 2017; 2017. <https:\/\/www.hzjz.hr\/wp-content\/uploads\/2017\/05\/PROVEDBENI-PROGRAM-II._2017.pdf>. [Accessed 29-11-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0200","unstructured":"Ministry of Social Affairs and Health. HPV Vaccinations; 2017. <http:\/\/stm.fi\/en\/hpv-vaccinations>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0205","unstructured":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. Questions-r\u00e9ponses \u2013 Vaccin anti-papillomavirus humain Gardasil\u00ae; 2017. <http:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/QR_Gardasil_26-11-2013.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0210","unstructured":"Bulletin \u00e9pid\u00e9miologique hebdomadaire. In\u00e9galit\u00e9s socio\u00e9conomiques d'acc\u00e8s \u00e0 la vaccination contre les infections \u00e0 papillomavirus humains en France: r\u00e9sultats de l'Enqu\u00eate sant\u00e9 et protection sociale (ESPS), 2012; 2017. <http:\/\/invs.santepubliquefrance.fr\/beh\/2016\/16-17\/2016_16-17_3.html>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0215","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. Gardasil\u00ae \u2013 Mise en place d'un plan national de gestion des risques \u2013 Communiqu\u00e9; 2017. <http:\/\/ansm.sante.fr\/S-informer\/Presse-Communiques-Points-presse\/Gardasil-R-Mise-en-place-d-un-plan-national-de-gestion-des-risques-Communique>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0220","unstructured":"Health Policy Monitor. HPV vaccination in Germany; 2017. <http:\/\/www.hpm.org\/de\/Surveys\/Bertelsmann_Stiftung_-_D\/10\/HPV_vaccination_in_Germany.html>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0225","unstructured":"Robert Koch Institute. Impfung gegen humane Papillomaviren (HPV) f\u00fcr M\u00e4dchen von 12 bis 17 Jahren \u2013 Empfehlung und Begr\u00fcndung; 2017. <https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2007\/Ausgabenlinks\/12_07.pdf?__blob=publicationFile>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0230","unstructured":"Robert Koch Institute. Empfehlungen der Standigen Impfkommission (STIKO) am Robert Koch Institut \u2013 Stand Juli 2007; 2017. <http:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2007\/Ausgabenlinks\/30_07.pdf?__blob=publicationFile>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12889-016-2831-5","article-title":"Greek health professionals' perceptions of the HPV vaccine, state policy recommendations and their own role with regards to communication of relevant health information","volume":"16","author":"Karamanidou","year":"2016","journal-title":"BMC Public Health"},{"issue":"33","key":"10.1016\/j.vaccine.2018.06.044_b0240","doi-asserted-by":"crossref","first-page":"18954","DOI":"10.2807\/ese.13.33.18954-en","article-title":"Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey","volume":"13","author":"King","year":"2008","journal-title":"Euro Surveill"},{"issue":"46","key":"10.1016\/j.vaccine.2018.06.044_b0245","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1016\/j.vaccine.2011.08.079","article-title":"Estimated acceptance of HPV vaccination among Italian women aged 18\u201326 years","volume":"29","author":"Giambi","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.044_b0250","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/1471-2458-12-498","article-title":"Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: insights from a behavioral survey among parents","volume":"12","author":"Gefenaite","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2018.06.044_b0255","unstructured":"Kemmeren J, de Melker H. The National Immunisation Programme in the Netherlands. Developments in 2009; 2010. <http:\/\/www.rivm.nl\/en\/Documents_and_publications\/Scientific\/Reports\/2010\/april\/The_National_Immunisation_Programme_in_the_Netherlands_Developments_in_2009>. [Accessed 9\/25\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2458-13-111","article-title":"Determinants of HPV vaccination intentions among Dutch girls and their mothers: a cross-sectional study","volume":"13","author":"van Keulen","year":"2013","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.044_b0265","first-page":"53","article-title":"Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide","volume":"69","author":"Owsianka","year":"2015","journal-title":"Przegl Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.044_b0270","first-page":"107","article-title":"The evolution of Polish immunization schedule during the last 10 years","volume":"66","author":"Mrozek-Budzyn","year":"2012","journal-title":"Przegl Epidemiol"},{"key":"10.1016\/j.vaccine.2018.06.044_b0275","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13027-015-0034-9","article-title":"Cross-sectional study about primary health care professionals views on the inclusion of the vaccine against human papillomavirus in the vaccine schedules","volume":"10","author":"Perez","year":"2015","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.vaccine.2018.06.044_b0280","unstructured":"Swedish Medical Center Health Library. Gardasil: An HPV Vaccine to Prevent Cervical Cancer; 2017. <http:\/\/swedishhospital.com\/hl\/?\/129302\/Gardasil--An-HPV-Vaccine-to-Prevent-Cervical-Cancer>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0285","unstructured":"Folkh\u00e4lsomyndigheten. Background to a vaccination programme for the human papilloma virus in Sweden 2007; 2017. <https:\/\/www.folkhalsomyndigheten.se\/contentassets\/fec148272e0d40a2a172fb9ab5ebb5fc\/background-to-a-vaccination-programme-for-the-human-papilloma-virus-in-sweden-2007-2008-132-2.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0290","unstructured":"Office f\u00e9d\u00e9ral de la sant\u00e9 publique OFSP. Plan de vaccination suisse 2014; 2017. <http:\/\/www.nitag-resource.org\/uploads\/media\/default\/0001\/01\/edd21531b9868eda0d1d11cb0e1d7d9124205ba1.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0295","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI). Human papillomavirus vaccines to protect against cervical cancer; 2017. <http:\/\/webarchive.nationalarchives.gov.uk\/20120907151322\/http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@ab\/documents\/digitalasset\/dh_094739.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0300","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Cervarix HPV vaccine: update on UK safety experience at end of 4 years use in the HPV routine immunisation programme; 2017. <https:\/\/assets.publishing.service.gov.uk\/media\/547307f540f0b6131200003d\/con213228.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0305","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-12-207","article-title":"Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective","volume":"12","author":"Weil-Olivier","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2018.06.044_b0310","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12325-013-0051-2","article-title":"A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis","volume":"30","author":"Tin Tin","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2018.06.044_b0315","unstructured":"Ministry of Health. PCV Tender announcement 2011 Bulgaria; 2017. <http:\/\/www.mh.government.bg\/media\/filer_public\/2015\/05\/28\/obiavlenie>. [Accessed 9\/25\/2017]."},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.044_b0320","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children\u2013a population-based study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.044_b0325","unstructured":"National Institute for Health and Welfare. Monitoring the population effectiveness of pneumococcal conjugate vaccination in the Finnish national vaccination programme; 2017. <https:\/\/www.thl.fi\/fi\/web\/thlfi-en\/research-and-expertwork\/projects-and-programmes\/monitoring-the-population-effectiveness-of-pneumococcal-conjugate-vaccination-in-the-finnish-national-vaccination-programme>. [Accessed 8\/7\/2017]."},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.044_b0330","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","article-title":"Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012","volume":"33","author":"Lepoutre","year":"2015","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2018.06.044_b0335","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1016\/j.vaccine.2012.06.068","article-title":"Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children","volume":"30","author":"van der Linden","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.044_b0340","doi-asserted-by":"crossref","first-page":"206757","DOI":"10.1155\/2015\/206757","article-title":"Impact of pneumococcal conjugate universal routine vaccination on pneumococcal disease in italian children","volume":"2015","author":"Fortunato","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2018.06.044_b0345","unstructured":"Centro Nazionale Di Epidemiologia SEPDS. Dati e evidenze disponibili per l'utilizzo dei vaccini anti-pneumococcici nei soggetti a rischio di qualsiasi et\u00e0 e per l'eventuale ampliamento dell'offerta ai soggetti anziani; 2017. <http:\/\/www.epicentro.iss.it\/temi\/vaccinazioni\/pdf\/Dati%20e%20evidenze%20vaccini%20antipneumococcici.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0350","unstructured":"Health Council of the Netherlands. Vaccination of infants against pneumococcal infections; 2005. <https:\/\/www.gezondheidsraad.nl\/en\/task-and-procedure\/areas-of-activity\/prevention\/vaccination-of-infants-against-pneumococcal>. [Accessed 8\/7\/2017]."},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.044_b0355","first-page":"55","article-title":"Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations","volume":"80","author":"Moreno-Perez","year":"2014","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.vaccine.2018.06.044_b0360","unstructured":"Ministerio de Sanidad Servicios Sociales e Igualdad. Preguntas y respuestas sobre el cambio del calendario com\u00fan de vacunaci\u00f3n infantil: Razones para la implantaci\u00f3n de un nuevo esquema de vacunaci\u00f3n; 2017. <http:\/\/www.msssi.gob.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/CalendarioVacunacion_PoblacionGeneral.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0365","unstructured":"Folkh\u00e4lsomyndigheten. Det svenska vaccinationsprogrammet for Barn; 2017. <https:\/\/www.folkhalsomyndigheten.se\/contentassets\/cb976ce43f66483b8a3371604d504ab4\/vaccination-barn-information-vardnadshavare-svenska-vaccinationsprogrammet.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0370","unstructured":"Internetmedicin. SP\u00c4DBARNSVACCINER; 2017. <http:\/\/www.internetmedicin.se\/page.aspx?id=2664>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0375","unstructured":"Office F\u00e9d\u00e9ral de la Sant\u00e9 Publique OFSP. Suivi cantonal de la couverture vaccinale en Suisse; 2017. <https:\/\/www.bag.admin.ch\/bag\/fr\/home\/themen\/mensch-gesundheit\/uebertragbare-krankheiten\/impfungen-prophylaxe\/informationen-fachleute-gesundheitspersonal\/durchimpfung.html>. [Accessed 9\/25\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0380","unstructured":"Green Book. Chapter 25 v6 Pneumococcal, March 2017; 2017. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/596441\/green_book_chapter__25.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0385","unstructured":"National Institute for Health and Welfare. Rokotusohjelman historia. <https:\/\/www.thl.fi\/fi\/web\/rokottaminen\/kansallinen-rokotusohjelma\/rokotusohjelman-historia>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0390","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI). Annual influenza vaccination programme 2012; 2017. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/224775\/JCVI-statement-on-the-annual-influenza-vaccination-programme-25-July-2012.pdf>. [Accessed 9\/25\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0395","unstructured":"Public Health England. Documents relating to the new meningococcal B (MenB) vaccination (Bexsero\u00ae) programme starting from 1 September 2015; 2016. <https:\/\/www.gov.uk\/government\/collections\/meningococcal-b-menb-vaccination-programme>. [Accessed 9\/5\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0400","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI statement on MenB; 2017. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/294245\/JCVI_Statement_on_MenB.pdf>. [Accessed 9\/5\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0405","unstructured":"KCE \u2013 Centre F\u00e9d\u00e9ral d'Expertise des Soins de Sant\u00e9. Use of pneumococcal vaccines in the elderly: an economic evaluation; 2017. <https:\/\/kce.fgov.be\/sites\/default\/files\/atoms\/files\/KCE_274C_Short-Report_Pneumococcal.pdf>. [Accessed 9\/25\/2017]."},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.044_b0410","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10096-014-2208-6","article-title":"Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?","volume":"34","author":"Torres","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.044_b0415","unstructured":"Vandepitte J. Pneumocoque; 1999. <http:\/\/www.vaxinfopro.be\/IMG\/pdf\/vax_23_fr.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0420","unstructured":"Robert Koch Institute. Empfelungen der standigen impfkommission am Robert Koch Institut 2006; 2006. <http:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2006\/Ausgabenlinks\/30_06.pdf?__blob=publicationFile>. [Accessed 10\/11\/2017]"},{"issue":"10","key":"10.1016\/j.vaccine.2018.06.044_b0425","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12325-014-0157-1","article-title":"Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe","volume":"31","author":"Castiglia","year":"2014","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2018.06.044_b0430","unstructured":"Ministero della Salute. Piano Nazionale Prevenzione Vaccinale 2012-2014; 2012. <http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_1721_allegato.pdf>. [Accessed 29-11-2017]."},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.044_b0435","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1099\/00222615-44-6-397","article-title":"Pneumococcal vaccine","volume":"44","author":"Mayon-White","year":"1996","journal-title":"J Med Microbiol"},{"issue":"48","key":"10.1016\/j.vaccine.2018.06.044_b0440","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.044_b0445","unstructured":"Sant\u00e9 Publique France \u2013 Institut de Veille Sanitaire. Calendrier des vaccinations et recommandations vaccinales 2016; 2017. <http:\/\/invs.santepubliquefrance.fr\/Publications-et-outils\/BEH-Bulletin-epidemiologique-hebdomadaire\/Archives\/2016\/BEH-hors-serie-Calendrier-des-vaccinations-et-recommandations-vaccinales-2016>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0450","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Vaccination des adultes contre le zona avec le vaccin Zostavax\u00ae; 2017. <https:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=389>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0455","unstructured":"Public Health England. Herpes zoster (shingles) immunisation programme 2013\/2014: Report for England; 2017. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/383018\/ShinglesReport2014.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0460","unstructured":"Public Health England. Shingles: guidance and vaccination programme; 2017. <https:\/\/www.gov.uk\/government\/collections\/shingles-vaccination-programme>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0465","unstructured":"Ministerium Frauen Gesundheit. BMG und WHO: Masern-Elimination in Europa m\u00f6glich und n\u00f6tig! 2017. <https:\/\/www.ots.at\/presseaussendung\/OTS_20150422_OTS0121\/bmg-und-who-masern-elimination-in-europa-moeglich-und-noetig>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0470","unstructured":"Offentliches Gesundheitsportal Osterreichs. Grippe: Impfstoff-Aktion in den Apotheken; 2017. <https:\/\/www.gesundheit.gv.at\/aktuelles\/archiv-2010\/grippe-aktuell.html-kh>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0475","unstructured":"VENICE National Gatekeepers. VENICE Work Package 3 \u2013 Report on Vaccination Coverage Assessment In Europe; 2017. <http:\/\/venice.cineca.org\/Final_Report_I_WP3.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0480","unstructured":"VENICE National Gatekeepers. VENICE Work package 4 - Vaccination coverage assessment in EU\/EEA, 2011; 2017. <http:\/\/venice.cineca.org\/Final_Vaccination_Coverage_Assesment_Survey_2011_1.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0485","unstructured":"Agentschap Zorg en Gezondheid. Gezondheidsdoelstelling vaccinaties; 2017. <https:\/\/www.zorg-en-gezondheid.be\/gezondheidsdoelstelling-vaccinaties>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0490","unstructured":"Government of Belgium. Measles Elimination Plan, Belgium, April 2004; 2017. <https:\/\/www.wiv-isp.be\/epidemio\/epien\/plaben\/measles.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0495","unstructured":"National Center for Infectious and Parasitic Diseases. Analysis of the implementation of the activities by immunoprophylaxis in Bulgaria in 2016; 2017. <https:\/\/www.ncipd.org\/index.php?option=com_docman&view=download&alias=122-analysis-immuno-activities&category_slug=epidemiologiya-i-nadzor&Itemid=1127&lang=bg>. [Accessed 9\/25\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0500","unstructured":"Childhood vaccinations in Croatia; 2012. <hrcak.srce.hr\/file\/138506>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0505","unstructured":"Croatian Institute of Public Health. Croatian Health Service Yearbook 2016; 2017. <https:\/\/www.hzjz.hr\/cat\/hrvatski-zdravstveno-statisticki-ljetopis\/>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0510","unstructured":"National Institute for Health and Welfare. Lasten rokotuskattavuus; 2017. <https:\/\/www.thl.fi\/roko\/rokotusrekisteri\/atlas\/atlas.html?show=infantbc>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0515","unstructured":"Statistical yearbook on social welfare and health care 2015. Seasonal influenza vaccination coverage for people aged 65 and over by hospital district, from season 2005-2006 to season 2014-2015; 2017. <http:\/\/www.julkari.fi\/bitstream\/handle\/10024\/129792\/Sosiaali-%20ja%20terveysalan%20tilastollinen%20vuosikirja%202015%20web.pdf#page=153>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0520","unstructured":"National Institute for Health and Welfare. Rokotusrekisteri. 2017. <https:\/\/www.thl.fi\/fi\/web\/rokottaminen\/kansallinen-rokotusohjelma\/rokotusrekisteri>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0525","unstructured":"National Institute for Health and Welfare. Vaccinations; 2017. <https:\/\/www.thl.fi\/fi\/web\/thlfi-en\/statistics\/information-on-statistics\/quality-descriptions\/vaccinations>."},{"key":"10.1016\/j.vaccine.2018.06.044_b0530","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Note de r\u00e9ponse \u00e0 la saisine de la Mme la ministre de la sant\u00e9 concernant les domaines d\u2019action prioritaires de la strat\u00e9gie nationale de sant\u00e9 et Compl\u00e9ment de r\u00e9ponse: proposition d\u2019objectifs de r\u00e9sultats \u00e0 5 et 10 ans; 2014. <http:\/\/www.hcsp.fr\/Explore.cgi\/avisrapportsdomaine?clefr=421>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0535","unstructured":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. La couverture vaccinale; 2017. <http:\/\/solidarites-sante.gouv.fr\/spip.php?page=recherche&recherche=la+couverture+vaccinale>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0540","unstructured":"Sant\u00e9 Publique France \u2013 Institut de Veille Sanitaire. Couverture Vaccinale; 2017. <http:\/\/invs.santepubliquefrance.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Couverture-vaccinale\/Donnees>. [Accessed 9\/5\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0545","unstructured":"DIMDI \u2013 German Institute of Medical Documentation and Information. Die Masern-Mumps-R\u00f6teln-Impfung aus gesundheitspolitischer und \u00f6konomischer Sicht; 2017. <https:\/\/portal.dimdi.de\/de\/hta\/hta_berichte\/hta138_bericht_de.pdf>. [Accessed 8\/7\/2017]."},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2018.06.044_b0550","first-page":"845","article-title":"Vaccination coverage in German adults: results of the German Health Interview and Examination Survey for Adults (DEGS1)","volume":"56","author":"Poethko-Muller","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.vaccine.2018.06.044_b0555","unstructured":"Robert Koch Institute. Aktuelles aus der KV-Impfsurveillance: Impfquoten der Rotavirus-, Masern-, HPV- und Influenza-Impfung in Deutschland; 2017. <https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2017\/Ausgaben\/01_17.pdf>. [Accessed 10\/3\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0560","unstructured":"Robert Koch Institute. Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2015; 2017. <https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2017\/Ausgaben\/16_17.pdf?__blob=publicationFile>. [Accessed 10\/3\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0565","unstructured":"Bundesministerium F\u00fcr Gesundheit. Nationaler Aktionsplan 2015\u20132020 zur Elimination der Masern und R\u00f6teln in Deutschland. <https:\/\/www.bundesregierung.de\/Content\/Infomaterial\/BMG\/_2746.html>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0570","unstructured":"Hellenic Center for Disease Control & Prevention. Measles; 2017. <http:\/\/www.keelpno.gr\/el-gr\/%CE%BD%CE%BF%CF%83%CE%AE%CE%BC%CE%B1%CF%84%CE%B1%CE%B8%CE%AD%CE%BC%CE%B1%CF%84%CE%B1%CF%85%CE%B3%CE%B5%CE%AF%CE%B1%CF%82\/%CE%BB%CE%BF%CE%B9%CE%BC%CF%8E%CE%B4%CE%B7%CE%BD%CE%BF%CF%83%CE%AE%CE%BC%CE%B1%CF%84%CE%B1\/%CE%BD%CE%BF%CF%83%CE%AE%CE%BC%CE%B1%CF%84%CE%B1%CF%80%CE%BF%CF%85%CF%80%CF%81%CE%BF%CE%BB%CE%B1%CE%BC%CE%B2%CE%AC%CE%BD%CE%BF%CE%BD%CF%84%CE%B1%CE%B9%CE%BC%CE%B5%CE%B5%CE%BC%CE%B2%CE%BF%CE%BB%CE%B9%CE%B1%CF%83%CE%BC%CF%8C\/%CE%B9%CE%BB%CE%B1%CF%81%CE%AC.aspx#22>. [Accessed 9\/25\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0575","unstructured":"Hellenic Center for Disease Control & Prevention. Report 2012; 2017. <http:\/\/www.keelpno.gr\/Portals\/0\/%CE%91%CF%81%CF%87%CE%B5%CE%AF%CE%B1\/%CE%94%CE%B7%CE%BC%CE%BF%CF%86%CE%B9%CE%BB%CE%AE-%CE%A3%CF%85%CE%BD%CE%AD%CE%B4%CF%81%CE%B9%CE%B1%20%CE%BA%CE%AC\/%CE%95%CE%B2%CE%B4%CE%BF%CE%BC%CE%AC%CE%B4%CE%B1%20%CE%95%CE%BC%CE%B2%CE%BF%CE%BB%CE%B9%CE%B1%CF%83%CE%BC%CE%BF%CF%8D%202012-2013\/ekthesi_emvolia_2012.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0580","unstructured":"EpiCentro \u2013 Il portale dell'epidemiologia per la sanit\u00e0 pubblica. Copertura vaccinale in Italia; 2017. <http:\/\/www.epicentro.iss.it\/temi\/vaccinazioni\/dati_Ita.asp>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0585","unstructured":"EpiCentro \u2013 Il portale dell'epidemiologia per la sanit\u00e0 pubblica. Vaccinazione antinfluenzale, i dati di copertura per la stagione 2014-2015; 2017. <http:\/\/www.epicentro.iss.it\/problemi\/influenza\/copertureAntinfluenzale2014-2015.asp>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0590","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Netherlands National Immunisation Programme 2016; 2017. <http:\/\/www.rivm.nl\/en\/Documents_and_publications\/Scientific\/Reports\/2016\/juni\/Immunisation_coverage_National_Immunisation_Programme_NIP_in_the_Netherlands_Year_of_report_2016>. [Accessed 9\/25\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0595","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. De pijlers van het Rijksvaccinatieprogramma; 2017. <http:\/\/www.rivm.nl\/Documenten_en_publicaties\/Algemeen_Actueel\/Uitgaven\/Infectieziekten_Bulletin\/Jaargang_23_2012\/Oktober_2012\/Inhoud_oktober_2012\/De_pijlers_van_het_Rijksvaccinatieprogramma>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0600","unstructured":"National Institute of Public Health. Vaccinations in Poland in 2016; 2017. <http:\/\/wwwold.pzh.gov.pl\/oldpage\/epimeld\/2016\/Sz_2016_wstepne_dane.pdf>. [Accessed 9\/27\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0605","unstructured":"Stefanoff P. Challenges in documenting childhood immunization in Poland; 2017. <http:\/\/www.oek.hu\/oekfile.pl?fid=3533>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0610","unstructured":"United Nations and Government of Romania. Millennium Development Goals \u2013 Romania 2010; 2017. <http:\/\/www.undp.ro\/download\/MDGR_Report_2010.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0615","unstructured":"Directia de Sanatate Publica Neamt. Privind instituirea metodologiei de raportare on-line \u00een Registrul unic de vaccin\u00e3ri; 2017. <http:\/\/www.sant.ro\/informatii-utile\/registre-nationale-de-sanatate\/renv\/OMS_1234_2011.pdf\/view>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0620","unstructured":"European Centre for Disease Prevention and Control. Ongoing outbreak of measles in Romania, risk of spread and epidemiological situation in EU\/EEA countries; 2017. <https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/27-02-2017-RRA-Measles-Romania,%20European%20Union%20countries.pdf>."},{"issue":"17","key":"10.1016\/j.vaccine.2018.06.044_b0625","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.2807\/ese.17.17.20159-en","article-title":"Vaccine registers \u2013 experiences from Europe and elsewhere","volume":"17","author":"Pebody","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.06.044_b0630","unstructured":"Ministerio de Sanidad Servicios Sociales e Igualdad. Coberturas De Primovacunaci\u00f3n. Series B\u00e1sicas. Espa\u00f1a 2007-2016; 2017. <http:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/CoberturasVacunacion\/Todas_las_tablas.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0635","unstructured":"Folkh\u00e4lsomyndigheten. National plan of action to prevent the spread of measles and rubella; 2017. <https:\/\/www.folkhalsomyndigheten.se\/publicerat-material\/publikationsarkiv\/n\/National-plan-of-action-to-prevent-the-spread-of-measles-and-rubella\/>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0640","unstructured":"Folkh\u00e4lsomyndigheten. Andel av befolkningen \u00f6ver 65 \u00e5r vaccinerad mot influensa, s\u00e4song 2014-2015; 2017. <https:\/\/www.folkhalsomyndigheten.se\/globalassets\/statistik-uppfoljning\/vaccinationsstatistik\/influensa\/influensa-vaccination-2014-2015.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0645","unstructured":"Folkh\u00e4lsomyndigheten. Nationella vaccinationsregister; 2017. <https:\/\/www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistikdatabaser-och-visualisering\/vaccinationsregister\/>. [Accessed 8\/7\/2017]."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2018.06.044_b0650","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/00333549111260S212","article-title":"The Swiss National Vaccination Coverage Survey, 2005\u20132007","volume":"126","author":"Lang","year":"2011","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2018.06.044_b0655","unstructured":"Office F\u00e9d\u00e9ral de la Sant\u00e9 Publique OFSP. Couverture vaccinale des enfants \u00e2g\u00e9s de 2, 8 et 16 ans en Suisse, 1999\u20132016; 2017. <https:\/\/www.bag.admin.ch\/bag\/fr\/home\/themen\/mensch-gesundheit\/uebertragbare-krankheiten\/impfungen-prophylaxe\/informationen-fachleute-gesundheitspersonal\/durchimpfung.html>. [Accessed 12\/11\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0660","unstructured":"Foundation Myvaccines. Der schweizerische elektronische Impfausweis; 2017. <https:\/\/www.meineimpfungen.ch\/login.html>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0665","unstructured":"NHS Wales Powys Teaching Health Board. Quality Key Performance Indicators: March 2015; 2017. <http:\/\/www.powysthb.wales.nhs.uk\/sitesplus\/documents\/1145\/Q%26S_3.1a_Quality%20Performance%20Indicator%20Report.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0670","doi-asserted-by":"crossref","first-page":"d5703","DOI":"10.1136\/bmj.d5703","article-title":"Improving MMR vaccination rates: herd immunity is a realistic goal","volume":"343","author":"Cockman","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2018.06.044_b0675","unstructured":"Public Health England. Flu Plan 2016\/17; 2017. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/525967\/Annual_flu_plan_2016_to_2017.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0680","unstructured":"Public Health England. Quarterly vaccination coverage statistics for children aged up to five years in the UK (COVER programme): January to March 2016; 2017. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/531021\/hpr2016_COVER.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0685","unstructured":"Public Health England. HPV vaccine coverage data for vaccinations given from 1 September 2014 to 31 August 2015 by local authority and area team; 2017. <https:\/\/www.gov.uk\/government\/statistics\/annual-hpv-vaccine-coverage-2014-to-2015-by-local-authority-and-area-team>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0690","unstructured":"Public Health England. Surveillance of influenza and other respiratory viruses in the United Kingdom: Winter 2015 to 2016; 2017. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/526405\/Flu_Annual_Report_2015_2016.pdf>. [Accessed 8\/7\/2017]."},{"issue":"16","key":"10.1016\/j.vaccine.2018.06.044_b0695","doi-asserted-by":"crossref","first-page":"20149","DOI":"10.2807\/ese.17.16.20149-en","article-title":"Measuring childhood vaccine coverage in England: the role of Child Health Information Systems","volume":"17","author":"Amirthalingam","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.06.044_b0700","unstructured":"Service NH. NHS public health functions agreement 2016-17 Service specification No.8 Pneumococcal immunisation programme; 2016."},{"key":"10.1016\/j.vaccine.2018.06.044_b0705","unstructured":"Public Health England. NHS public health functions agreement 2017-18 Service specification No.14 Shingles (herpes zoster) immunisation programme; 2017. <https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2017\/04\/service-spec-14.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0710","unstructured":"European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases; 2017. <https:\/\/ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0715","unstructured":"European Centre for Disease Prevention and Control. Annual epidemiological report for 2016 \u2013 Hepatitis B; 2017. <https:\/\/ecdc.europa.eu\/en\/publications-data\/hepatitis-b-annual-epidemiological-report-2016-2014-data>. [Accessed 9\/25\/2017]."},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.044_b0720","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/her\/cyu027","article-title":"Mass media coverage of HPV vaccination in Romania: a content analysis","volume":"29","author":"Penta","year":"2014","journal-title":"Health Educ Res"},{"key":"10.1016\/j.vaccine.2018.06.044_b0725","unstructured":"World Health Organization. Vaccine-preventable diseases: monitoring system 2017 global summary; 2017. <http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tscoveragebcg.html>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0730","unstructured":"Ministerium Frauen Gesundheit. HPV-Impfung. <http:\/\/www.bmgf.gv.at\/home\/Gesundheit\/Gesundheitsfoerderung_Praevention\/Impfen\/HPV_Impfung>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0735","unstructured":"Institut Scientifique de Sant\u00e9 Publique. GEZONDHEIDSENQUETE 2013 \u2013 Rapport 5: Preventie; 2017. <https:\/\/his.wiv-isp.be\/nl\/Gedeelde%20%20documenten\/VA_NL_2013.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0740","unstructured":"HPV Information Centre. Human Papillomavirus and Related Diseases Report- Belgium. <http:\/\/www.hpvcentre.net\/statistics\/reports\/BEL.pdf>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0745","unstructured":"National Center for Infectious and Parasitic Diseases. Notifications and vaccine coverage rate 2008\u20132015 Bulgaria; 2017. <https:\/\/www.ncipd.org\/index.php?option=com_docman&view=list&slug=analizi-na-zaraznite-zabolyavaniya&Itemid=1127&lang=bg>. [Accessed 10\/11\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0750","unstructured":"European Centre for Disease Prevention and Control. Seasonal influenza vaccination programme country profile: Croatia 2012\u20132013; 2017. <https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Report%20Assets\/seasonal-vaccination-coverage-in-europe-2012-13\/Seasonal-Influenza-Vaccination-Programme-Country-Profile-Croatia.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0755","unstructured":"National Institute for Health and Welfare. Sosiaali- ja terveysalan tilastollinen vuosikirja 2015; 2017. <http:\/\/www.julkari.fi\/bitstream\/handle\/10024\/129792\/Sosiaali-%20ja%20terveysalan%20tilastollinen%20vuosikirja%202015%20web.pdf#page=15>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0760","unstructured":"National Institute for Health and Welfare. HPV-rokotuksista kysytty\u00e4. <https:\/\/www.thl.fi\/fi\/web\/rokottaminen\/kaytannon-ohjeita\/usein-kysyttya\/hpv-rokotuksista-kysyttya>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0765","unstructured":"Sant\u00e9 Publique France \u2013 Institut de Veille Sanitaire. Couverture vaccinale dipht\u00e9rie, t\u00e9tanos, poliomy\u00e9lite et coqueluche; 2017. <http:\/\/invs.santepubliquefrance.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Couverture-vaccinale\/Donnees\/Diphterie-tetanos-poliomyelite-coqueluche>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0770","unstructured":"Sant\u00e9 Publique France \u2013 Institut de Veille Sanitaire. Couverture vaccinale grippe par saison et dans chaque groupe d'\u00e2ge; 2017. <http:\/\/invs.santepubliquefrance.fr\/\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Couverture-vaccinale\/Donnees\/Grippe>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0775","unstructured":"Sant\u00e9 Publique France \u2013 Institut de Veille Sanitaire. Couverture vaccinale \u2013 Papillomavirus-humains. <http:\/\/invs.santepubliquefrance.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Couverture-vaccinale\/Donnees\/Papillomavirus-humains>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0780","doi-asserted-by":"crossref","unstructured":"Poethko-Muller C, Buttmann-Schweiger N, KiGGS Study Group. Impfstatus und Determinanten der Impfung gegen humane Papillomviren (HPV) bei M\u00e4dchen in Deutschland; 2014. <http:\/\/edoc.rki.de\/oa\/articles\/ree7Rqqhphoo\/PDF\/25eanQ1UbJVyw.pdf>. [Accessed 1-12-2017]","DOI":"10.1007\/s00103-014-1987-3"},{"key":"10.1016\/j.vaccine.2018.06.044_b0785","unstructured":"HPV Information Centre. Human Papillomavirus and Related Diseases Report-Greece. <http:\/\/www.hpvcentre.net\/statistics\/reports\/GRC.pdf>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0790","unstructured":"Ministero della Salute. Vaccinazioni dell'et\u00e0 pediatrica. Anno 2016; 2017. <http:\/\/www.salute.gov.it\/imgs\/C_17_tavole_20_allegati_iitemAllegati_0_fileAllegati_itemFile_5_file.pdf>. [Accessed 9\/5\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0795","unstructured":"Ministero della Salute. Coperture vaccinali al 31\/12\/2015 per HPV; 2017. <http:\/\/www.salute.gov.it\/imgs\/C_17_tavole_27_allegati_iitemAllegati_0_fileAllegati_itemFile_0_file.pdf>. [Accessed 9\/5\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0800","unstructured":"Ministero della Salute. Vaccinazione antinfluenzale in Italia: coperture vaccinali negli anziani (et\u00e0 >= 65 anni) (per 100 abitanti) (2016-2017); 2017. <http:\/\/www.salute.gov.it\/imgs\/C_17_tavole_19_allegati_iitemAllegati_0_fileAllegati_itemFile_3_file.pdf>. [Accessed 9\/5\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0805","unstructured":"Ministero della Salute. Dati coperture vaccinali \u2013 Influenza; 2017. <http:\/\/www.salute.gov.it\/portale\/influenza\/dettaglioContenutiInfluenza.jsp?lingua=italiano&id=679&area=influenza&menu=vuoto>. [Accessed 9\/5\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0810","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Rapporten 2015-2016. <http:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2015-0067.xlsx>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0815","unstructured":"National Institute of Public Health. Vaccinations in Poland in 2014; 2014. <http:\/\/wwwold.pzh.gov.pl\/oldpage\/epimeld\/2014\/Sz_2014.pdf>. [Accessed 11\/10\/2017]."},{"issue":"16","key":"10.1016\/j.vaccine.2018.06.044_b0820","doi-asserted-by":"crossref","first-page":"20780","DOI":"10.2807\/1560-7917.ES2014.19.16.20780","article-title":"Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008\/09), pandemic (2009\/10) and post-pandemic (2010\/11)","volume":"19","author":"Mereckiene","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.06.044_b0825","unstructured":"HPV Information Centre. Human Papillomavirus and Related Diseases Report-Romania. <http:\/\/www.hpvcentre.net\/statistics\/reports\/ROU.pdf>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0830","unstructured":"Ministerio de Sanidad Servicios Sociales e Igualdad. Coberturas de Vacunaci\u00f3n. Datos Estad\u00edsticos; 2017. <http:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/coberturas.htm>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0835","unstructured":"Folkh\u00e4lsomyndigheten. Barnvaccinationsprogrammet i Sverige 2014; 2017. <https:\/\/www.folkhalsomyndigheten.se\/contentassets\/0e837971b3a647f3a839df10e80999bf\/arsrapport-barnvaccinationsprogramet-2014-15032.pdf>. [Accessed 8\/7\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0840","unstructured":"HPV Information Centre. Sweden \u2013 Human Papillomavirus and Related Cancers, Fact Sheet; 2017. <http:\/\/www.hpvcentre.net\/statistics\/reports\/SWE_FS.pdf>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0845","unstructured":"Public Health England. Vaccine uptake guidance and the latest coverage data; 2017. <https:\/\/www.gov.uk\/government\/collections\/vaccine-uptake>. [Accessed 8\/7\/2017]."},{"issue":"289","key":"10.1016\/j.vaccine.2018.06.044_b0850","first-page":"1","article-title":"Vaccination programs for older adults in an era of demographic change","volume":"9","author":"Doherty","year":"2018","journal-title":"Eur Geriatr Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.044_b0855","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/07853890.2017.1417632","article-title":"Challenges in adult vaccination","volume":"50","author":"de Gomensoro","year":"2018","journal-title":"Ann Med"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2018.06.044_b0860","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/1469-0691.12537","article-title":"Lifelong vaccination as a key disease-prevention strategy","volume":"20","author":"Bonanni","year":"2014","journal-title":"Clin Microbiol Infect: Official Publ Eur Soc Clin Microbiol Infect Diseases"},{"key":"10.1016\/j.vaccine.2018.06.044_b0865","unstructured":"Carlgren A. Council recommendation of 22 December 2009 on seasonal influenza vaccination; 2009. <http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF>. [Accessed 8\/21\/2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0870","unstructured":"Sozialgesetzbuch. Law for the Prevention and Control of Infectious Diseases in Humans (Infection Protection Act \u2013 IfSG), 10a. <http:\/\/www.sozialgesetzbuch-sgb.de\/ifsg\/34.html>. [Accessed 1-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0875","unstructured":"Ministero della Salute. Decreto vaccini, le disposizioni per l\u2019anno scolastico 2017\/2018 per agevolare scuole e famiglie; 2017. <http:\/\/www.salute.gov.it\/portale\/vaccinazioni\/dettaglioNotizieVaccinazioni.jsp?lingua=italiano&menu=notizie&p=dalministero&id=3065>. [Accessed 4-12-2017]."},{"key":"10.1016\/j.vaccine.2018.06.044_b0880","unstructured":"Gouvernement France. 8 nouveaux vaccins obligatoires pour les enfants de moins de 2 ans; 2017. <http:\/\/www.gouvernement.fr\/argumentaire\/8-nouveaux-vaccins-obligatoires-pour-les-enfants-de-moins-de-2-ans>. [Accessed 4-12-2017]."}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2019.01.038","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T20:04:00Z","timestamp":1661544240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":176,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18308727"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A report on the status of vaccination in Europe","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}